JUNXIU Biotech has long focused on biomedical materials and high-end implantable medical devices, with a commitment to advancing tissue repair and regenerative medicine through innovative material technologies.
Supported by an independent R&D system, sustained investment in technology, and deep industry-academia-research collaboration, the company has established an integrated innovation ecosystem spanning fundamental research, patented technologies, standards development, academic research, and industrial translation.
In recent years, JUNXIU Biotech has continued to advance its global strategy, actively participating in international academic exchange and medical device industry collaboration. Through high-quality biomaterials for tissue repair and innovative solutions, the company serves healthcare markets worldwide.
Independent Innovation Powers Core Technology Development and Sustainable R&D
As a biomedical materials company driven by technological innovation, JUNXIU Biotech remains focused on key technologies in tissue repair, biomaterials, and regenerative medicine.
Recently, two core invention patents independently developed by the company were officially granted by the China National Intellectual Property Administration. The patents cover technologies related to:
- Bioadhesives
- Bone-filling materials
Both patents originated from the company’s independent R&D system and provide a strong technological foundation for the development and application of high-performance medical devices.
Shaping Industry Standards to Advance the Standardized Development of Peripheral Nerve Repair Materials
Drawing on its long-standing technical expertise in biologically derived tissue-repair materials, JUNXIU Biotech actively contributes to the development of medical device industry standards. Through this work, the company seeks to promote a more standardized, safe, and sustainable future for peripheral nerve repair materials.
Relevant standards in whose development and drafting the company participated have been officially published and implemented, including:
YY/T 1951—2024
Tissue-Engineered Medical Device Products—General Requirements for Biologically Derived Peripheral Nerve Repair Implants
This is one of China’s important technical specifications for biologically derived peripheral nerve repair implant materials. It provides a reference framework for product R&D, quality evaluation, testing and verification, and clinical application.
GB/T 44418—2024
Assistive Products for Rehabilitation—Cognitive Accessibility—Guidelines for Daily Time Management
This standard addresses a gap in China’s standards for accessible time-management assistive products for people with cognitive impairments. It also helps standardize the domestic development, manufacturing, and fitting services of rehabilitation assistive products while aligning with international accessible-design systems.
Deepening International Research Collaboration to Accelerate the Translation of Regenerative Medicine Innovations
JUNXIU Biotech places strong emphasis on scientific innovation and international academic collaboration. The company has established long-term partnerships with universities and research institutions to continuously explore innovative applications of biomedical materials in tissue repair.
Relevant research has been published in international academic journals, including:
- Chemical Engineering Journal: Synergistic antioxidant-antimicrobial-immunomodulatory self-healing “radical sponge” hydrogel for diabetic wound regeneration via microenvironment reprogramming mediated by coordinated MAPK suppression and PI3K-AKT activation
- Frontiers in Microbiology: Bioinspired electrospun janus nanofibrous dressing for synergistic antibacterial activity and tissue regeneration
These studies provide ongoing scientific support for the company’s technological innovation and product development.
Connecting Industry and Education to Support Medical Device Talent Development
Leveraging its experience in medical device R&D, industrial translation, and industry practice, JUNXIU Biotech contributed to the writing of Introduction to Medical Devices (2nd Edition), a core textbook for medical device programs at higher vocational colleges across China.
The company incorporated practical experience in medical device development, industry standards, and biomaterials innovation into the textbook, strengthening the connection between industrial practice and professional education. By contributing to talent development, JUNXIU Biotech actively supports knowledge transfer and the growth of future professionals in the medical device field.
Closing the Innovation Loop and Delivering Chinese Biomedical Material Solutions to the Global Market
From independent R&D and intellectual property development to industry standards and international research collaboration—and from industrial application to professional talent development—JUNXIU Biotech has progressively built a complete innovation system covering:
01 Research & Development
02 Intellectual Property
03 Academic Collaboration
04 Industry Standards
05 Commercial Application
Looking ahead, JUNXIU Biotech will remain focused on innovation in biomedical materials and regenerative medicine technologies. The company is committed to providing healthcare institutions, partners, and patients worldwide with safer, more effective, and more reliable tissue-repair solutions, while working together with global stakeholders to advance the regenerative medicine industry.